LobbyingMedicare Access To Skin Substitutes Coalition lobbying by quarter
Medicare Access To Skin Substitutes Coalition's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $200K. Its first report covers Q3 2023; the issues it reports most are Medicare/Medicaid.
Medicare Access To Skin Substitutes Coalition
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $200K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $40K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $130K | 1 |
| Q3 2024 | $130K | 1 |
| Q4 2024 | $90K | 1 |
| Q1 2025 | $110K | 1 |
| Q2 2025 | $90K | 1 |
| Q3 2025 | $140K | 1 |
| Q4 2025 | $120K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$930K · 10 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)10 reports
- HOUSE OF REPRESENTATIVES7 reports
- SENATE7 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| King & Spalding | $930K | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EMILY DUHOVNY SILVERBERG | Apr 2025-May 2026 Deputy Chief of Staff/Legislative Director Jan 2021-Apr 2025 Legislative Director May 2014-Jan 2020 Senior Legislative/Policy Advisor Jan 2013-April 2018 Staff/Legislative Assistant Sep 2012-Jan 2013 Congressional Intern. | Q2 2026 |
| SCOTT DZIENGELSKI | Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017) | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | King & Spalding | $40K |
| 04/20for Q1 | King & Spalding | $40K |
| 01/19for Q4 2025 | King & Spalding | $120K |
| 25/10/19for Q3 2025 | King & Spalding | $140K |
| 25/07/21for Q2 2025 | King & Spalding | $90K |
| 25/04/17for Q1 2025 | King & Spalding | $110K |
| 25/01/21for Q4 2024 | King & Spalding | $90K |
| 24/10/20for Q3 2024 | King & Spalding | $130K |
| 24/07/21for Q2 2024 | King & Spalding | $130K |
| 24/04/19for Q1 2024 | King & Spalding | Under $5,000 |
| 24/01/15for Q4 2023 | King & Spalding | Under $5,000 |
| 23/10/16for Q3 2023 | King & Spalding | $40K |
| 23/09/29for Q3 2023 | King & Spalding | Under $5,000 |